TransMedics Group (TMDX) awards RSUs and stock options to officer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TransMedics Group, Inc. officer Nicholas Corcoran reported equity compensation awards. He received 11,727 restricted stock units (RSUs), each representing a contingent right to one share of common stock, bringing his direct common stock holdings to 41,558 shares.
He was also granted a stock option for 17,784 shares of common stock at an exercise price of $71.23 per share, expiring on July 10, 2036. The option vests at 2.0833% per month starting after April 10, 2026 and is scheduled to be fully vested by April 10, 2030, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Corcoran Nicholas
Role
See remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,784 | $0.00 | -- |
| Grant/Award | Common Stock | 11,727 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 17,784 shares (Direct);
Common Stock — 41,558 shares (Direct)
Footnotes (1)
- Consists of 11,727 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.
Key Figures
RSUs Granted: 11,727 RSUs
Option Shares Granted: 17,784 shares
Option Exercise Price: $71.23 per share
+3 more
6 metrics
RSUs Granted
11,727 RSUs
Restricted stock units granted to Nicholas Corcoran on July 10, 2026
Option Shares Granted
17,784 shares
Stock option (right to buy) granted to Nicholas Corcoran
Option Exercise Price
$71.23 per share
Conversion or exercise price of the stock option
Option Expiration
July 10, 2036
Expiration date of the granted stock option
Post-Grant Common Holdings
41,558 shares
Total common stock held directly after RSU grant
Option Vesting Rate
2.0833% per month
Monthly vesting rate from after April 10, 2026 to April 10, 2030
Key Terms
restricted stock units, RSUs, Stock Option (Right to Buy), vesting
4 terms
restricted stock units financial
"Consists of 11,727 restricted stock units ("RSUs"). Each RSU represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Consists of 11,727 restricted stock units ("RSUs"). Each RSU represents a contingent right"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with 17,784.0000 shares and a $71.2300 exercise price"
vesting financial
"The option vests at a rate of 2.0833% of the total number of shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What equity awards did Nicholas Corcoran report in the Form 4 for TMDX?
Nicholas Corcoran reported 11,727 RSUs and a stock option for 17,784 shares of TransMedics Group, Inc. common stock, both granted as equity compensation on July 10, 2026.
How many RSUs did Nicholas Corcoran receive from TransMedics Group (TMDX)?
He received 11,727 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of TransMedics Group, Inc. common stock, subject to the applicable vesting and service conditions.
What are the key terms of Nicholas Corcoran’s stock option from TMDX?
The stock option covers 17,784 shares at an exercise price of $71.23 per share, expiring on July 10, 2036, providing a long-dated right to purchase TransMedics common stock if vesting conditions are met.
What is the vesting schedule for Nicholas Corcoran’s TransMedics stock option?
The option vests at 2.0833% per month of the total shares starting after April 10, 2026 and is expected to be fully vested by April 10, 2030, conditioned on continued service.
Do Nicholas Corcoran’s RSUs in TMDX provide immediate common stock?
No. The 11,727 RSUs represent a contingent right to receive one share of TransMedics common stock per unit, typically delivered as the RSUs vest over time.